{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:27:01Z","timestamp":1793953621441,"version":"4.8.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.rmed.2026.108789","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:18:17Z","timestamp":1774372697000},"page":"108789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Mapping the clinical use of inhaled bacteriophages in respiratory infections caused by multidrug-resistant pathogens: a scoping review"],"prefix":"10.1016","volume":"256","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5765-533X","authenticated-orcid":false,"given":"Irene","family":"Terzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios","family":"Drakopanagiotakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Rafailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2026.108789_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4161\/viru.25991","article-title":"A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens","volume":"5","author":"Wittebole","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.rmed.2026.108789_bib2","first-page":"1199","article-title":"GBD 2021 antimicrobial resistance collaborators, global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2026.108789_bib3","article-title":"Bacteriophages presence in nature and their role in the natural selection of bacterial populations","volume":"91","author":"Naureen","year":"2020","journal-title":"Acta Biomed."},{"key":"10.1016\/j.rmed.2026.108789_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s13205-024-04101-8","article-title":"Phage therapy: a novel approach against multidrug-resistant pathogens","volume":"14","author":"Kapoor","year":"2024","journal-title":"3 Biotech"},{"key":"10.1016\/j.rmed.2026.108789_bib5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/17425247.2017.1252329","article-title":"Inhaled phage therapy: a promising and challenging approach to treat bacterial respiratory infections","volume":"14","author":"Bodier-Montagutelli","year":"2017","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.rmed.2026.108789_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.758392","article-title":"Prospects of inhaled phage therapy for combatting pulmonary infections","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.rmed.2026.108789_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3390\/v11030295","article-title":"Towards inhaled phage therapy in Western Europe","volume":"11","author":"Wienhold","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.rmed.2026.108789_bib8","doi-asserted-by":"crossref","DOI":"10.1089\/jamp.2021.0045","article-title":"Inhaled delivery of anti-pseudomonal phages to tackle respiratory infections caused by superbugs","volume":"35","author":"Chan","year":"2022","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.rmed.2026.108789_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01470-20","article-title":"Pharmacokinetics and time-kill study of inhaled antipseudomonal bacteriophage therapy in mice","volume":"65","author":"Chow","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rmed.2026.108789_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/pathogens8030100","article-title":"Bacteriophages in natural and artificial environments","volume":"8","author":"Batinovic","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.rmed.2026.108789_bib11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3390\/antibiotics14050487","article-title":"Virological and pharmaceutical properties of clinically relevant phages","volume":"14","author":"Panagiotopoulos","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.rmed.2026.108789_bib12","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.3390\/cells12162057","article-title":"Stability considerations for bacteriophages in liquid formulations designed for nebulization","volume":"12","author":"Flint","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.rmed.2026.108789_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51742-4","article-title":"Improved lyophilization conditions for long-term storage of bacteriophages","volume":"9","author":"Manohar","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.rmed.2026.108789_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2017.09.002","article-title":"Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection","volume":"121","author":"Chang","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.rmed.2026.108789_bib15","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1093\/cid\/ciad555","article-title":"Advanced manufacturing, formulation and microencapsulation of therapeutic phages","volume":"77","author":"Malik","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rmed.2026.108789_bib16","first-page":"200","volume":"42","author":"Pathak","year":"2025"},{"key":"10.1016\/j.rmed.2026.108789_bib17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3390\/v15030602","article-title":"Administration of bacteriophages via nebulization during mechanical ventilation: in vitro study and lung deposition in macaques","volume":"15","author":"Le Guellec","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.rmed.2026.108789_bib18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3390\/antibiotics13090870","article-title":"A comprehensive review on phage therapy and phage-based drug development","volume":"13","author":"Cui","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.rmed.2026.108789_bib21","article-title":"Inhalation phage therapy as a new approach to preventing secondary bacterial pneumonia in patients with moderate to severe COVID-19: a double-blind clinical trial study","volume":"84","author":"Samaee","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.rmed.2026.108789_bib22","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/s41564-024-01705-x","article-title":"Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicenter, multinational, retrospective observational study","volume":"9","author":"Pirnay","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.rmed.2026.108789_bib23","article-title":"Cystic fibrosis bacteriophage study at yale (CYPHY)","volume":"209","author":"Stanley","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.108789_bib24","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1093\/ofid\/ofad500.2474","article-title":"Nebulized phage therapy for patients with cystic fibrosis with chronic Pseudomonas aeruginosa pulmonary infection: a phase 1b\/2a randomized, double \u2013 blind, placebo-controlled, multicenter study","volume":"10","author":"Rappo","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.rmed.2026.108789_bib25","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41591-025-03678-8","article-title":"Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis","volume":"31","author":"Chan","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.rmed.2026.108789_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2025.2451048","article-title":"Exploration of the feasibility of clinical application of phage treatment for multidrug-resistant serratia marcescens-induced pulmonary infection","volume":"14","author":"Duan","year":"2025","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.rmed.2026.108789_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1432703","article-title":"Phage therapy for extensively drug resistant Acinetobacter baumannii infection: case report and in vivo evaluation of the distribution of phage and the impact on gut microbiome","volume":"11","author":"Qu","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.rmed.2026.108789_bib26","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.medj.2024.05.017","article-title":"Neutralizing antibodies after nebulized phage therapy in cystic fibrosis patients","volume":"5","author":"Bernab\u00e9u-Gimeno","year":"2024","journal-title":"Med"},{"key":"10.1016\/j.rmed.2026.108789_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1354681","article-title":"Personalized triple phage-antibiotic combination therapy to rescue necrotizing fasciitis caused by panton-valentine leukocidin-producing MRSA in a 12-year-old boy","volume":"14","author":"Van Nieuwenhuyse","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.rmed.2026.108789_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199442","article-title":"Safety and tolerability of bronchoscopic and nebulised administration of bacteriophage","volume":"348","author":"Singh","year":"2024","journal-title":"Virus Res."},{"key":"10.1016\/j.rmed.2026.108789_bib41","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3390\/v16071080","article-title":"Phage therapy in a burn patient colonized with extensively drug-resistant Pseudomonas aeruginosa responsible for relapsing ventilator-associated pneumonia and bacteriemia","volume":"16","author":"Teney","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.rmed.2026.108789_bib28","article-title":"Bacteriophage therapy for pan-drug-resistant Pseudomonas aeruginosa in two persons with cystic fibrosis","volume":"11","author":"Hahn","year":"2023","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"10.1016\/j.rmed.2026.108789_bib44","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.2147\/IDR.S413900","article-title":"Refractory Pseudomonas aeruginosa bronchopulmonary infection after lung transplantation for common variable immunodeficiency despite maximal treatment including IgM\/IgA-enriched immunoglobulins and bacteriophage therapy","volume":"16","author":"Lev\u00eaque","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.rmed.2026.108789_bib36","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1038\/s41467-023-39370-z","article-title":"Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa","volume":"14","author":"K\u00f6hler","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.rmed.2026.108789_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14041","article-title":"Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug-resistant Burkholderia multivorans","volume":"25","author":"Haidar","year":"2023","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.rmed.2026.108789_bib38","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/1751-7915.14217","article-title":"First-in-human application of double-stranded RNA bacteriophage in the treatment of pulmonary Pseudomonas aeruginosa infection","volume":"16","author":"Li","year":"2023","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.rmed.2026.108789_bib29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/cid\/ciac453","article-title":"Phage therapy of mycobacterium infections: compassionate use of phages in 20 patients with drug-resistant mycobacterial disease","volume":"76","author":"Dedrick","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rmed.2026.108789_bib45","doi-asserted-by":"crossref","first-page":"158","DOI":"10.5582\/bst.2022.01147","article-title":"Bacteriophage therapy for empyema caused by carbapenem-resistant Pseudomonas aeruginosa","volume":"16","author":"Chen","year":"2022","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.rmed.2026.108789_bib30","first-page":"413","article-title":"Inhaled bacteriophage therapy for multi-drug resistant achromobacter","volume":"95","author":"Winzig","year":"2022","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.rmed.2026.108789_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00824-21","article-title":"Critically ill patient with multidrug-resistant Acinetobacter baumannii respiratory infection successfully treated with intravenous and nebulized bacteriophage therapy","volume":"66","author":"Rao","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.rmed.2026.108789_bib31","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3390\/v13101901","article-title":"Phage therapy experience at the eliava phage therapy center: three cases of bacterial persistence","volume":"13","author":"Zaldastanishvili","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.rmed.2026.108789_bib48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/v13010060","article-title":"A case of phage therapy against pandrug-resistant Achromobacter xylosoxidans in a 12-year-old lung-transplanted cystic fibrosis patient","volume":"13","author":"Lebeaux","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.rmed.2026.108789_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.631585","article-title":"Clinical experience of personalized phage therapy against carbapenem-resistant Acinetobacter baumannii lung infection in a patient with chronic obstructive pulmonary disease","volume":"11","author":"Tan","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.rmed.2026.108789_bib40","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/22221751.2021.1902754","article-title":"Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients","volume":"10","author":"Wu","year":"2021","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.rmed.2026.108789_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/antibiotics9050232","article-title":"Bacteriophage therapy for critical infections related to cardiothoracic surgery","volume":"9","author":"Rubalskii","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.rmed.2026.108789_bib32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s15010-019-01319-0","article-title":"Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient","volume":"47","author":"Law","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.rmed.2026.108789_bib43","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1164\/rccm.201904-0839LE","article-title":"Bacteriophage therapy of ventilator-associated pneumonia and empyema caused by Pseudomonas aeruginosa","volume":"200","author":"Maddocks","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2026.108789_bib46","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1111\/ajt.15503","article-title":"Early clinical experience of bacteriophage therapy in 3 lung transplant recipients","volume":"19","author":"Aslam","year":"2019","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.rmed.2026.108789_bib33","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.resmic.2018.05.001","article-title":"Phage therapy against acthromobacter xylosaxidans lung infection in a patient with cystic fibrosis: a case report","volume":"169","author":"Hoyle","year":"2018","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.rmed.2026.108789_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/emph\/eov018","article-title":"Horizontal gene transfer","volume":"2015","author":"Burmeister","year":"2015","journal-title":"Evol. Med. Public Health"},{"key":"10.1016\/j.rmed.2026.108789_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/v15081736","article-title":"Genetic engineering and biosynthesis technology: Keys to unlocking the chains of phage therapy","volume":"15","author":"Lv","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.rmed.2026.108789_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00290-18","article-title":"Orphan genes shared by pathogenic genomes are more associated with bacterial pathogenicity","volume":"4","author":"Entwistle","year":"2019","journal-title":"mSystems"},{"key":"10.1016\/j.rmed.2026.108789_bib53","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/jac\/dkw083","article-title":"Bacteriophage therapy: a regulatory perspective","volume":"71","author":"Pelfrene","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.rmed.2026.108789_bib54","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/cid\/cix184","article-title":"The lysis of pathogenic Escherichia coli by bacteriophages releases less endotoxin than by \u03b2-Lactams","volume":"64","author":"Dufour","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rmed.2026.108789_bib55","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/antibiotics12020381","article-title":"The battle between bacteria and bacteriophages: a conundrum to their immune system","volume":"12","author":"Teklemariam","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.rmed.2026.108789_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2055","article-title":"Interaction of phages, bacteria, and the human immune system: evolutionary changes in phage therapy","volume":"29","author":"Jariah","year":"2019","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.rmed.2026.108789_bib57","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/BTT.S381237","article-title":"Phage therapy: a different approach to fight bacterial infections","volume":"16","author":"Hibstu","year":"2022","journal-title":"Biol. Targets & Ther."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126001575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126001575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:01:27Z","timestamp":1793952087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126001575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":55,"alternative-id":["S0954611126001575"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108789","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping the clinical use of inhaled bacteriophages in respiratory infections caused by multidrug-resistant pathogens: a scoping review","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108789"}}